35 related articles for article (PubMed ID: 7713278)
1. Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe.
Franco DR; Baptista J; Abreu FR; Batista RB; Eliaschewitz FG
World J Diabetes; 2014 Feb; 5(1):69-75. PubMed ID: 24567803
[TBL] [Abstract][Full Text] [Related]
2. Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors.
Koschinsky T; Heckermann S; Heinemann L
J Diabetes Sci Technol; 2008 Jan; 2(1):58-66. PubMed ID: 19885178
[TBL] [Abstract][Full Text] [Related]
3. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
[TBL] [Abstract][Full Text] [Related]
4. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
[TBL] [Abstract][Full Text] [Related]
5. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
6. InDuo, a novel combined insulin injection and blood glucose monitoring device - effective and save as other devices, and patient preference.
Haupt A; Berg B; Paschen P; Dreyer M; Häring HU; Smedegaard J; Skovlund SE; Matthaei S
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):541-4. PubMed ID: 16235158
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two intensified conventional insulin regimens with three and four daily injections.
Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
[TBL] [Abstract][Full Text] [Related]
8. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
Moberg EA; Lins PE; Adamson UK
Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
[TBL] [Abstract][Full Text] [Related]
9. Insulin management of type I and type II diabetes in pregnancy.
Hare JW
Clin Obstet Gynecol; 1991 Sep; 34(3):494-504. PubMed ID: 1934701
[No Abstract] [Full Text] [Related]
10. Self-monitoring of blood glucose levels in diabetes. Principles and practice.
Bergman M; Felig P
Arch Intern Med; 1984 Oct; 144(10):2029-34. PubMed ID: 6385899
[TBL] [Abstract][Full Text] [Related]
11. [Does the renal threshold change? Insulin therapy, based on urine glucose concentration, controlled by a dosage-measuring computer].
Hermányi I; Deutsoh T; Tamás G
Orv Hetil; 1989 Jun; 130(24):1269-72. PubMed ID: 2671856
[TBL] [Abstract][Full Text] [Related]
12. [Conventional or functional insulin therapy?].
Waldhäusl W; Howorka K; Bratusch-Marrain P
Wien Klin Wochenschr; 1988 Jun; 100(13):430-5. PubMed ID: 3043912
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
